Featured today on @MIT News! We provide large-scale evidence that we are facing a #mentalhealth crisis during #COVID19 found across many mental health #reddit support groups that should alarm us and hopefully bring more resources, especially to clinicians news.mit.edu/2020/covid-19-i…
💝🇦🇷💝
#Salvemoslacienciaargentina
Estudiantes, egresados, científicos argentinos de Harvard y MIT, apoyamos el reclamo por un presupuesto q permita la continuidad y excelencia de las universidades públicas en Argentina, gratuitas, motor d desarrollo para nuestro país 👇
1/3 Our study, now available in JSLHR, integrates spontaneous reports and package inserts to uncover medicines that could impact speech biomarkers.
doi.org/10.1044/2023_JSLHR-2…
Arndis Simonsen @StephanieBorrie, @danielmlow@AlbertoParola2 Emanuel Raschi Elisabetta Poluzzi @fusaroli
With increasing research on speech biomarkers for neuropsychiatric conditions, we should (also) worry about heterogeneity. Here we used pharmaco-surveillance techniques to uncover potential confounds by medication: medrxiv.org/content/10.1101/… Comments welcome. Thread to come
Last night's @CAUSALab networking event was a big success!
This is a new offering for our participants taking the @CAUSALab Summer Courses in-person at @HarvardChanSPH.
It's a great opportunity for students across the globe & different institutions to connect w/one another.
Workshop coming up this Friday org by @AlbertoParola2!
Voice- and speech-based markers of neuropsychiatric conditions: assessing methodological foundations for clinical application
Hybrid event, sign up to join & all are welcome!
Details and Programme: bit.ly/3XhsyH4
Very cool talk by @ddlcoppersmith on applying decision-making theory in analyzing how individuals predict their future suicidal ideation @ABCTNOW#abct2022
Jupyter Notebook is the most powerful tool Python developers have.
But most people don’t know the hidden features.
Need a quick web app?
Or to create REST APIs?
Here's the 6 ways to use Jupyter notebook you never knew existed:
📢 ¿Vieron el cronograma detallado del 2° #EncuentroRELIF? Agenden el lunes 25/07 y el jueves 28/07, que se vienen con dos plenarias en las que participan invitades de lujo 🤩 .
Si todavía no se inscribieron como asistentes, este es el momento:
✍️ relif.net.ar/inscripcion/
Amazing work by @ddlcoppersmith and team on the effects of increasing the sampling rate of EMA studies to better capture trends in suicidal thinking! #SRS22
Really enjoying the first day of @SAAscience! @ddlcoppersmith presented really exciting work combining traditional EMA intensity questions on suicidal ideation with qualitative text data about the content of such thoughts. Cool dynamic lexical network analysis!
1/
Our findings on a fourth dose (2nd booster) of the Pfizer-BioNTech #COVID19 vaccine are now published.
Compared with 3 doses only, a fourth dose had 68% effectiveness against COVID-19 hospitalization during the Omicron era in persons over 60 years of age.
Interestingly...
In Israel, a fourth dose of BNT162b2 vaccine effective in reducing the short-term risk of Covid-19–related outcomes among those who had received a third dose at least 4 mos earlier. nej.md/3r3W8kR
📢 New work by @DavidAcunzo@danielmlow#ScottFairhall now out in @NeuroImage_EiC
🔬 They formed a CNN to capture topic meaning from the combinations of words in sentences and contrasted this to a model treating words as discrete units irrespective of topic.
Última recomendación de la semana. En este caso, una NOVEDAD ✨ Con entusiasmo les cuento que vamos a dar un curso con @VAbusamra, Ale Villar, Aldo Ferreres y @danielmlow sobre Neuropsicología del lenguaje en la Escuela de Graduados de la Asociación Médica Argentina.